Purdue To Hold Off On Oxycontin Generics Until Federal Circuit Ruling
Generics maker Endo Pharmaceuticals has decided to hold off on launching its 10mg, 20mg and 40mg strengths oxycodone extended-release tablets until after an appellate rules in its litigation with The Purdue...To view the full article, register now.
Already a subscriber? Click here to view full article